Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells

  1. Paniagua-Herranz, L.
  2. Díaz-Tejeiro, C.
  3. Sanvicente, A.
  4. Bartolomé, J.
  5. Nieto-Jiménez, C.
  6. Ocana, A.
Revue:
Frontiers in Immunology

ISSN: 1664-3224

Année de publication: 2024

Volumen: 15

Type: Révision

DOI: 10.3389/FIMMU.2024.1432015 GOOGLE SCHOLAR lock_openAccès ouvert editor